---
title: "Västra Hamnen Market Focus: CombiGene: Making place for new ventures"
date: "2025-02-14 16:21:01"
summary: "• All research activities discontinued• Notice of an extraordinary general meeting on February 20, 2025• Q&amp;A with chairman Luca Di StefanoAfter a strategic evaluation of its operations, CombiGene’s board decided to discontinue all research activities and lay off personnel. In the light of the operational and business changes made, the..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

• All research activities discontinued

• Notice of an extraordinary general meeting on February 20, 2025

• Q&A with chairman Luca Di Stefano

After a strategic evaluation of its operations, CombiGene’s board decided to discontinue all research activities and lay off personnel. In the light of the operational and business changes made, the company has issued a notice of an extraordinary general meeting to be held on February 20, 2025. The EGM will also decide to authorise the board to decide on the issuance of new shares, warrants or convertibles, with or without deviation from the shareholders’ preferential rights.

To provide further insights, Västra Hamnen Corporate Finance reached out to the newly appointed chairman Luca Di Stefano.

Read the full report here.

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-14:newsml_MFN6Cw704:0-v-stra-hamnen-market-focus-combigene-making-place-for-new-ventures/)
